All In Biotech

Drug Trial Radar · NCT03047395

A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)

Last checked: Nov 20, 2026Latest source record: Dec 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,170

Actual

Start

Feb 27, 2017

Primary completion

Nov 29, 2023

Study completion Nov 29, 2023

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Feb 9, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the long-term safety and efficacy of risankizumab in the treatment of moderate to severe chronic plaque psoriasis.

Conditions

  • Psoriasis

Interventions

  • risankizumabBiological

    Risankizumab 150 mg administered by subcutaneous injection every 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Serious Adverse Events and Non-Serious Adverse EventsTime frame: Median follow-up time of 1905 days

Locations

233 sites in 17 countries. Site status is shown where the registry gives one.

  • Total Skin and Beauty Dermatology Center /ID# 154000

    Birmingham, Alabama

  • University of Alabama at Birmingham - Main /ID# 153983

    Birmingham, Alabama

  • NW Arkansas Clinical Trials Center /ID# 154014

    Rogers, Arkansas

  • Bakersfield Derma & Skin Cance /ID# 154008

    Bakersfield, California

  • California Dermatology and Research Institute /ID# 154007

    Encinitas, California

  • T. Joseph Raoof, MD, Inc. /ID# 154078

    Encino, California

  • Center for Dermatology Clinical Research /ID# 154009

    Fremont, California

  • Kaiser Permanente Los Angeles /ID# 154079

    Los Angeles, California

  • Dermatology Research Associates /ID# 153977

    Los Angeles, California

  • Wallace Medical Group /ID# 154025

    Los Angeles, California

  • Dermatology Specialists, Inc /ID# 153984

    Oceanside, California

  • Huntington Medical Foundation /ID# 154002

    Pasadena, California

  • Medderm Associates /ID# 154098

    San Diego, California

  • Southern California Dermatology /ID# 154006

    Santa Ana, California

  • UNISON Center for Clinical Tri /ID# 153979

    Sherman Oaks, California

  • New England Research Associates, LLC /ID# 154004

    Bridgeport, Connecticut

  • UConn Health /ID# 154128

    Farmington, Connecticut

  • Florida Academic Centers Research /ID# 154045

    Coral Gables, Florida

  • Leavitt Medical Associates of Florida /ID# 154046

    Ormond Beach, Florida

  • Progressive Medical Research /ID# 154027

    Port Orange, Florida

  • Hamilton Research, LLC /ID# 153980

    Alpharetta, Georgia

  • Advanced Medical Research, PC /ID# 153999

    Sandy Springs, Georgia

  • Northwestern University Feinberg School of Medicine /ID# 153974

    Chicago, Illinois

  • Rush University Medical Center /ID# 154099

    Chicago, Illinois

  • Arlington Dermatology /ID# 153975

    Rolling Meadows, Illinois

  • Northshore University Health System Dermatology Clinical Trials Unit /ID# 154011

    Skokie, Illinois

  • Dundee Dermatology /ID# 154110

    West Dundee, Illinois

  • Dawes Fretzin, LLC /ID# 154146

    Indianapolis, Indiana

  • The Dermatology Center PSC - New Albany /ID# 154075

    New Albany, Indiana

  • The Indiana Clinical Trials Center /ID# 153976

    Plainfield, Indiana

  • The South Bend Clinic Center /ID# 154147

    South Bend, Indiana

  • Epiphany Dermatology of Kansas LLC /ID# 153993

    Overland Park, Kansas

  • Skin Sciences, PLLC /ID# 153991

    Louisville, Kentucky

  • DS Research /ID# 154028

    Louisville, Kentucky

  • Massachusetts General Hospital /ID# 153990

    Boston, Massachusetts

  • ActivMed Practices and Research, LLC. /ID# 154044

    Methuen, Massachusetts

  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 154111

    Ann Arbor, Michigan

  • Great Lakes Research Group - Bay City /ID# 153998

    Bay City, Michigan

  • Michigan Center for Skin Care Research /ID# 153986

    Clinton Township, Michigan

  • Somerset Skin Centre /ID# 154097

    Troy, Michigan

Showing 40 of 233 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.